Nai-Dong Chen | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Posted on by ScienceFather

Prof. Nai-Dong Chen | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

department leader at West Anhui University, China

Professor Chen, born in September 1972 in Jinzhai County, Anhui Province, is a distinguished scholar and a leading figure in the field of traditional Chinese medicine and natural product research. Currently, he serves as a Distinguished Professor (Dabieshan Scholar) at West Anhui University, where he also holds multiple leadership roles, including Deputy Director of the Experimental Teaching and Training Management Department, and Director of the Postdoctoral Research Workstation. He is a doctoral supervisor affiliated with Anhui University of Chinese Medicine and Anhui Agricultural University, and leads the Anhui Provincial Key Laboratory of Traditional Chinese Medicine Quality Evaluation and Enhancement. Prof. Chen is also the head of several strategic research teams and innovation platforms that focus on the modernization and industrialization of herbal medicine. A nationally recognized talent under the Anhui Provincial Special Support Plan, he has been honored as a Top Talent of Lu’an City, Outstanding Teaching Faculty of West Anhui University, and nominee for Lu’an Distinguished Talent Award. His scholarly influence is reinforced by his role as a reviewer for the National Natural Science Foundation and active participation in national academic societies, contributing to both academic and practical advancements in pharmaceutical science.

Professional Profile

Education

Professor Chen holds a PhD in Pharmaceutical Sciences, which provided the foundation for his career-long dedication to the research and development of traditional Chinese medicine. With a strong academic background rooted in pharmacy, chemistry, and biotechnology, his educational journey integrated classical medicinal knowledge with modern scientific methodology. Over the years, he has further enhanced his qualifications through postdoctoral research and continuous academic training, establishing himself as a multidisciplinary expert. His early education fostered a strong commitment to scientific excellence and innovation, particularly in areas such as medicinal chemistry, pharmacology, and natural product extraction. His academic milestones have been complemented by hands-on experience in laboratory work, clinical trials, and academic leadership. Prof. Chen’s teaching and mentorship roles at institutions such as Anhui University of Chinese Medicine and Anhui Agricultural University reflect a solid academic lineage and dedication to nurturing the next generation of researchers. His consistent academic growth, paired with strategic collaboration with scientific institutions, has enabled him to contribute meaningfully to the evolving landscape of pharmaceutical education in China. His educational achievements form the intellectual backbone of his extensive work in TCM standardization, drug development, and plant-based biomedicine.

Professional Experience

Throughout his career, Professor Chen has accumulated a wealth of professional experience spanning academia, research administration, and national-level scientific leadership. As a Professor at West Anhui University, he has played a pivotal role in curriculum development, talent cultivation, and institutional research strategy. He concurrently serves as Vice Secretary of the Party Committee and Deputy Director of the Experimental Training Management Department, while also leading the Postdoctoral Workstation and provincial laboratories in quality enhancement of traditional Chinese medicine. Prof. Chen is the Chief Investigator and Team Leader of several key innovation teams focused on medicinal plant research and pharmacological innovation. Beyond his university, he is deeply involved in provincial and national science policymaking, contributing as a Communications Reviewer for NSFC, and as a standing member of the Chinese Under-Forest Economy Society and Anhui Botanical Society. Over the years, he has led or participated in over 20 major scientific research projects, with total funding in the multimillion-yuan range. His work often bridges the gap between academia and industry, evidenced by extensive industry-academic collaboration, numerous patents, and standard-setting activities. His experience reflects a mature balance of teaching, research, and service that defines his leadership in Chinese pharmaceutical sciences.

Research Interests

Professor Chen research interests center on the quality evaluation, efficacy enhancement, and innovation of traditional Chinese medicines (TCMs). A key focus of his work is the phytochemistry, pharmacokinetics, and bioactivity of medicinal herbs, particularly Dendrobium huoshanense, a rare and valuable plant species. His investigations delve into metabolomics, network pharmacology, and structure-activity relationships, aiming to improve standardization and therapeutic potential of herbal products. He has also led efforts to decode the geographical specificity (daodi) and biological transformation mechanisms of active components in medicinal plants. His interest in synergistic fermentation, antioxidant activity, and enzyme inhibition studies has resulted in innovative methods for improving bioavailability and therapeutic outcomes of plant-based compounds. Additionally, Professor Chen integrates modern analytical technologies such as UPLC-MS/MS, NIR spectroscopy, and bioinformatics into his research toolkit, enhancing the precision and scalability of TCM research. His collaborative work with pharmaceutical companies aims to commercialize novel herbal formulations and functional health products. As TCM gains global interest, Prof. Chen’s research aligns with the trend of merging traditional knowledge with cutting-edge biomedical science, addressing critical issues in herbal medicine safety, efficacy, and modernization.

Awards and Honors

Professor Chen has been recognized with numerous prestigious awards and honors, reflecting his profound impact on pharmaceutical research and education. Among his most notable achievements are two Second Prizes for Science and Technology Progress in Anhui Province and the Special Award for Technological Advancement by the China General Chamber of Commerce. These accolades signify his contributions to both fundamental science and its practical application in the modernization of traditional Chinese medicine. He was also honored with the Anhui Provincial Teaching Achievement Award (Second Prize), highlighting his role in academic innovation and pedagogy. As a recipient of the Anhui Provincial Leading Talent under the Special Support Plan, Prof. Chen is acknowledged as a strategic scientific leader. He has been awarded Top Talent and Outstanding Scholar titles in Lu’an City, and recognized as a Teaching Master at West Anhui University. His selection as Principal Investigator for National Natural Science Foundation of China (NSFC) projects further underscores his status in China’s scientific community. With over 40 patent applications, 23 industry and local standards developed, and extensive mentorship roles, his accolades are both deep and diverse. These honors confirm his legacy as a highly influential and respected figure in biomedical and TCM research.

Conclusion

Professor 陈乃东 is a highly suitable candidate for the Best Researcher Award. His outstanding achievements in TCM quality research, natural products pharmacology, and regional development through science and innovation reflect the hallmarks of a leading researcher. His contributions are scientifically rigorous, socially relevant, and academically influential. With minor enhancements in global engagement and innovation translation, his profile could further stand out on the world stage.

Publications Top Notes

  • Author(s): Hao, Jingwen; Wang, Weiting; Chen, Naidong; Shen, Yan
    Year: 2025
    Title: Identification of 13 natural antioxidants in green calyx plum using AAPH, ABTS, and FRAP-coupled HPLC-DAD via QTOF-MS/MS
    Journal: Food Chemistry
    Citations: 0

  • Author(s): Chen, Naidong
    Year: 2025
    Title: Mechanism for the Inhibition of α-Glucosidase by Peptide Tyr-Pro-Ile-Trp (YPIW) and Its Stability
    Journal: Shipin Kexue / Food Science
    Citations: 0

  • Author(s): Zheng, Shaojun; Li, Sheng; Diao, Xiaohan; Chen, Naidong
    Year: 2025
    Title: Prunus mume Alleviates Hyperuricemic Renal Injury: Insights From Network Pharmacology and Experimental Models
    Journal: Biomedical Chromatography
    Citations: 0

  • Author(s): Hao, Kuku; Wang, Qijin; Wei, Shengxiang; Zheng, Shaojun; Zhang, Manman; Chen, Naidong (co-author)
    Year: 2025
    Title: Structural characterization and anti-inflammatory activity of a neutral polysaccharide from Dendrobium huoshanense C. Z. Tang et S. J. Cheng
    Journal: International Journal of Biological Macromolecules
    Citations: 0

  • Author(s): Hao, Jingwen; Fan, Xuanxuan; Chen, Naidong; Xiao, Jun; Zhang, Manman
    Year: 2025
    Title: A novel method for the simultaneous determination of flavonoids in Pteridium aquilinum via SPE combined with UPLC-DAD via QAMS
    Journal: Journal of Food Composition and Analysis
    Citations: 0

 

Mrs. fangyan He | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Posted on by ScienceFather

Mrs. fangyan He | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Senior Experimentalist at Yunnan University of Traditional Chinese Medicine, China

He Fangyan is a distinguished researcher specializing in the pharmacodynamics and pharmacokinetics of traditional Chinese medicine. Currently serving as a Senior Experimentalist at Yunnan University of Traditional Chinese Medicine, she has led multiple high-impact studies focusing on ischemic stroke mechanisms and brain pharmacokinetics. With a commitment to advancing neuropharmacology, she has secured prestigious research grants, contributed to key scientific advancements, and developed innovative methodologies in cerebral ischemia treatment. Her expertise extends to drug metabolism, blood-brain barrier protection, and targeted drug delivery, making her a prominent figure in the field. Through her patents, publications, and ongoing research, she continues to bridge the gap between traditional Chinese medicine and modern pharmacological science.

Professional Profile

Education

He Fangyan holds an advanced degree in pharmacology and traditional Chinese medicine research, equipping her with interdisciplinary expertise in both experimental and clinical pharmacokinetics. She has undergone rigorous training in drug absorption, metabolism, and pharmacodynamics, particularly focusing on ischemic stroke therapies. Her academic background includes specialized studies in cerebral ischemia-reperfusion injury and neuroprotection, which laid the foundation for her innovative research contributions. She has further enhanced her knowledge through postgraduate research projects, technical training in pharmacological analysis, and collaborations with leading scientists in neurological drug development. Her education has provided her with a strong analytical and methodological foundation, enabling her to conduct cutting-edge research in traditional Chinese medicine’s role in stroke management.

Professional Experience

With extensive experience in experimental pharmacology and neuroscience, He Fangyan has held a senior research position at Yunnan University of Traditional Chinese Medicine, leading multiple research projects funded by national and provincial grants. She has played a pivotal role in advancing traditional Chinese medicine applications for stroke treatment, particularly through the study of Gastrodia’s neuroprotective effects. Over the years, she has worked on high-impact studies integrating brain microdialysis, PK/PD modeling, and oxidative stress mechanisms. In addition to academic research, she has contributed to methodology development in neuropharmacology, ensuring precise drug targeting and evaluation of traditional medicine compounds. Her professional contributions also extend to mentoring young researchers and fostering interdisciplinary collaborations, strengthening the field of pharmacokinetics and neuroprotection.

Research Interests

He Fangyan’s primary research interests revolve around cerebral ischemia, blood-brain barrier protection, and pharmacokinetics of traditional Chinese medicine compounds. She is particularly focused on understanding the mechanisms of ischemic stroke and the therapeutic potential of Gastrodia-derived compounds in treating oxidative stress-induced brain damage. Her studies employ microdialysis techniques, drug metabolism analysis, and neuroprotective compound development, making significant contributions to stroke research. She is also deeply invested in the translation of traditional Chinese medicine principles into modern pharmacological applications, aiming to bridge ancient remedies with contemporary scientific methodologies. Additionally, she explores novel drug delivery systems and prodrug mechanisms, ensuring targeted treatment with minimal side effects for cerebrovascular diseases.

Awards and Honors

He Fangyan has been recognized for her outstanding contributions to traditional Chinese medicine research and neuropharmacology. She has received funding from prestigious institutions such as the National Natural Science Foundation of China and the Yunnan Science and Technology Department, reflecting the significance of her work. Her patented innovations in cerebral ischemia treatment have earned acclaim, contributing to advancements in stroke therapy. She has also published extensively in SCI-indexed journals, further solidifying her academic reputation. As a key figure in pharmacokinetics and stroke research, she has been invited to speak at academic conferences and collaborate on national research initiatives. Her dedication to scientific progress and innovation continues to garner recognition, positioning her as a leading researcher in the field of traditional Chinese medicine and neuroscience.

Conclusion

He Fangyan is a strong candidate for the Best Researcher Award due to extensive contributions to pharmacokinetics and stroke research, significant grant funding, patents, and high-impact journal publications. Strengthening industry ties, international collaborations, and academic outreach could further solidify eligibility for top-tier research awards.

Publications Top Noted

  • He, F., Feng, J., Sun, H., Xu, Y., Yan, H., Song, X., Wang, Y., Li, X., & Lin, Q. (2024). Protective Effect of Protocatechuic Aldehyde on Cerebral Ischemia/Reperfusion Injury in Rats through Blood–Brain Barrier Protection. Bulletin of Experimental Biology and Medicine. https://doi.org/10.1007/s10517-024-06264-z

  • He, F., Xu, C., Feng, J., Sun, H., Yan, M., Yang, Q., Zhou, X., Yang, J., & Lin, Q. (2024). Pharmacokinetics of 4-Hydroxybenzaldehyde in Normal and Cerebral Ischemia–Reperfusion Injury Rats Based on Microdialysis Technique. European Journal of Drug Metabolism and Pharmacokinetics. https://doi.org/10.1007/s13318-023-00863-3

  • He, F., Ma, C., Feng, J., Li, X., Xia, S., Lin, Q., Dai, R., & He, F. (2021). Angiogenesis effects of 4-methoxy benzyl alcohol on cerebral ischemia-reperfusion injury via regulation of VEGF-Ang/Tie2 balance. Canadian Journal of Physiology and Pharmacology. https://doi.org/10.1139/cjpp-2021-0118

  • He, F., Dai, R., Zhou, X., Li, X., Song, X., Yan, H., Meng, Q., Yang, C., & Lin, Q. (2019). Protective effect of 4-Methoxy benzyl alcohol on the neurovascular unit after cerebral ischemia reperfusion injury. Biomedicine & Pharmacotherapy. https://doi.org/10.1016/j.biopha.2019.109260

  • He, F., Duan, X., Dai, R., Li, Y., & Lin, Q. (2017). Protective Effect of 4-Methoxy Benzyl Alcohol on the Blood–Brain Barrier after Cerebral Ischemia Reperfusion Injury. Journal of Stroke and Cerebrovascular Diseases. https://doi.org/10.1016/j.jstrokecerebrovasdis.2017.01.018

 

Nceba Gqaleni | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Posted on by ScienceFather

Prof. Nceba Gqaleni | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Research Professor at University of KwaZulu-Natal, South Africa

Professor Nceba Gqaleni is a renowned academic and researcher at the University of KwaZulu-Natal, South Africa. He currently serves as an Acting Academic Leader in the Discipline of Traditional Medicine and as a Research Professor. With a passion for integrating traditional medicine into mainstream healthcare, his research aims to address health challenges facing Africa, including HIV, diabetes, and cancer. His work on herbal treatments and immunomodulators has positioned him as a pioneer in exploring alternative therapies. Prof. Gqaleni’s research is characterized by the synergy between modern science and indigenous knowledge systems, contributing significantly to the global healthcare landscape. His work continues to impact public health, with ongoing clinical trials and innovative studies aimed at improving health outcomes. Additionally, he is committed to training the next generation of researchers, having mentored numerous postdoctoral, PhD, and master’s students.

Professional Profile

Education

Professor Nceba Gqaleni’s educational background is rooted in biochemistry, with a PhD in Biochemistry from the University of Strathclyde in Glasgow, UK. He also holds a Master’s degree in Biochemistry from the University of KwaZulu-Natal (UKZN), South Africa. His academic journey has been marked by a deep interest in both the molecular and traditional aspects of medicine, leading him to pursue research that bridges these fields. His formal education laid the foundation for a distinguished career in both academia and research, where he has applied his scientific expertise to explore alternative therapies and the integration of traditional medicine into contemporary health systems. Prof. Gqaleni’s educational path reflects a commitment to advancing knowledge and improving healthcare, particularly in the African context.

Professional Experience

Professor Gqaleni’s professional experience spans academia, research, and leadership. He currently holds the position of Acting Academic Leader in the Discipline of Traditional Medicine at the University of KwaZulu-Natal. His role involves guiding academic initiatives and research in traditional medicine, while also providing leadership in curriculum development and research supervision. In addition to his academic responsibilities, Prof. Gqaleni has led numerous significant research projects, particularly focused on traditional medicine’s role in addressing major health issues such as HIV and diabetes. His extensive work in supervising postgraduate students, including over 7 postdoctoral researchers, 12 PhD candidates, and 25 master’s students, demonstrates his dedication to nurturing the next generation of scholars and researchers. Prof. Gqaleni’s professional experience is a blend of academic excellence, mentorship, and groundbreaking research in the field of traditional medicine and biochemistry.

Research Interests

Professor Nceba Gqaleni’s research interests lie at the intersection of biochemistry and traditional medicine, with a primary focus on finding alternative treatments for diseases prevalent in Africa, such as HIV, diabetes, and cancer. He has led pioneering research on herbal compositions for the treatment of HIV and is currently conducting clinical trials for a patented HIV cure. In addition to HIV, his research extends to cancer therapies, immunomodulators, and the application of Indigenous phytotherapy in managing diseases like diabetes and HIV. Prof. Gqaleni’s ongoing research projects also explore the health and wellness of Indigenous peoples, particularly in the context of climate change and global health disparities. His work is driven by the goal of bridging the gap between traditional healing practices and modern medical approaches, thereby improving health outcomes in African communities and globally.

Awards and Honors

Professor Nceba Gqaleni’s career has been marked by significant achievements and recognition. He has been honored for his pioneering work in traditional medicine and biochemistry, particularly in the field of HIV and diabetes treatment. One of his notable accomplishments is the filing of a patent for a herbal composition aimed at curing HIV, which is currently undergoing clinical trials. Prof. Gqaleni has also received substantial funding for his research, including a $4.4 million NIH grant for a study on Indigenous phytotherapy. His contributions to science and public health have earned him the respect of both academic and medical communities. Prof. Gqaleni’s work in advancing the integration of traditional medicine into global health systems continues to garner international attention and recognition. His awards and honors reflect his exceptional leadership and groundbreaking contributions to healthcare research.

Conclusion

Professor Nceba Gqaleni demonstrates exceptional potential for the Best Researcher Award due to his innovative contributions to HIV treatment, integration of traditional medicine, and impactful mentorship. His work addresses critical health challenges in Africa, blending traditional knowledge with modern scientific methods. While broader dissemination and commercialization efforts could strengthen his profile, his contributions make him a strong contender for the award.

Publications Top Noted

  • Indigenous Medicinal Plants Used in the Management of Diabetes in Africa: 5 Years (2019–2024) in Perspective
    • Authors: Frimpong, E.K., Thembane, N., Hlatshwayo, S., Ngcobo, M., Gqaleni, N.
    • Year: 2024
    • Citations: 2
  • Review on the Anti-Hyperglycemic Potential of Psidium guajava and Seriphium plumosum L.
    • Authors: Thembane, N., Hlatshwayo, S., Ngcobo, M., Ngubane, P., Gqaleni, N.
    • Year: 2024
    • Citations: 1
  • Erratum: An in vitro study to elucidate the effects of Product Nkabinde on immune response in peripheral blood mononuclear cells of healthy donors
    • Authors: Setlhare, B., Letsoalo, M., Nkabinde, S.A., Ngcobo, M., Gqaleni, N.
    • Year: 2024
    • Citations: 0
  • An in vitro study to elucidate the effects of product Nkabinde on immune response in peripheral blood mononuclear cells of healthy donors
    • Authors: Setlhare, B., Letsoalo, M., Nkabinde, S.A., Ngcobo, M., Gqaleni, N.
    • Year: 2024
    • Citations: 1
  • Analysis of Three Species of Cassipourea Traditionally Used for Hypermelanosis in Selected Provinces in South Africa
    • Authors: Mpofana, N., Yalo, M., Gqaleni, N., Dlova, N.C., Hussein, A.A.
    • Year: 2024
    • Citations: 0
  • Melasma in People with Darker Skin Types: A Scoping Review Protocol on Prevalence, Treatment Options for Melasma, and Impact on Quality of Life
    • Authors: Mpofana, N., Chibi, B., Gqaleni, N., Kgarosi, K., Dlova, N.C.
    • Year: 2023
    • Citations: 3
  • The Effect of Melasma on the Quality of Life in People with Darker Skin Types Living in Durban, South Africa
    • Authors: Mpofana, N., Paulse, M., Gqaleni, N., Hussein, A., Dlova, N.C.
    • Year: 2023
    • Citations: 0
  • The Met and Unmet Health Needs for HIV, Hypertension, and Diabetes in Rural KwaZulu-Natal, South Africa: Analysis of a Cross-Sectional Multimorbidity Survey
    • Authors: Singh, U., Olivier, S., Cuadros, D., Ramnanan, A., Harilall, S., Gqaleni, N.
    • Year: 2023
    • Citations: 5
  • An Investigation into the Acute and Subacute Toxicity of Extracts of Cassipourea flanaganii Stem Bark In Vivo
    • Authors: Mpofana, N., Chipangura, J.K., Paulse, M., Hussein, A.A., Crouch, N.R.
    • Year: 2023
    • Citations: 2
  • Treatment of Melasma on Darker Skin Types: A Scoping Review
    • Authors: Mpofana, N., Chibi, B., Visser, T., Hussein, A.A., Dlova, N.C.
    • Year: 2023
    • Citations: 4

 

Olga Moskalenko | Medicine | Best Researcher Award

Posted on by ScienceFather

Assoc Prof Dr. Olga Moskalenko | Medicine | Best Researcher Award

Candidate of Biological Sciences, Russia

Olga Leonidovna Moskalenko is a dedicated educator and researcher in the fields of pediatrics, psychology, and medical education. With extensive training in various medical and pedagogical disciplines, she has established herself as a prominent figure in her field. 🌟

Publication Profile

Scopus

Education

Olga graduated from the Krasnoyarsk State Medical Academy in 2005, specializing in Pediatrics. She has pursued multiple advanced training programs in Medical Informatics, Pedagogical Education, and Psychology, further enriching her knowledge and skills. 🎓

Experience

She currently serves as an Associate Professor at the Krasnoyarsk State Medical University, where she contributes to the Department of Histology, Cytology, and Embryology. Additionally, she holds the position of Senior Researcher at the Research Institute of Medical Problems of the North, showcasing her commitment to advancing medical research and education. 🏥

Research Interests

Olga’s research focuses on critical topics such as internet addiction in adolescents, psychological interviewing, and pathophysiology. Her work aims to address significant psychological and health issues impacting young people today. 🔬

Awards

Throughout her career, Olga has led numerous scientific projects and received grants for her research on internet addiction and cancer diagnostics, reflecting her dedication to improving health outcomes in her community. 🏆

Publications

Griffiths, M. D., & Moskalenko, O. L. (2024). Title of the Publication. Journal Name.

Moskalenko, O. L. (2021). Title of the Publication. Journal Name.

Moskalenko, O. L. (2020). Title of the Publication. Journal Name.